Uniform Biological Material Transfer Agreement – MTA

Definitions

1. PROVIDER: Organization providing the ORIGINAL MATERIAL. The name and address of this party will be specified in an implementing letter.
2. PROVIDER SCIENTIST: The name and address of this party will be specified in an implementing letter.
3. RECIPIENT: Organization receiving the ORIGINAL MATERIAL. The name and address of this party will be specified in an implementing letter.
4. RECIPIENT SCIENTIST: The name and address of this party will be specified in an implementing letter.
5. ORIGINAL MATERIAL: The description of the material being transferred will be specified in an implementing letter.
6. MATERIAL: ORIGINAL MATERIAL, and PROGENY. The MATERIAL shall not include: (a) MODIFICATIONS, or (b) other substances created by the RECIPIENT through the use of the MATERIAL which are not MODIFICATIONS, PROGENY, or UNMODIFIED DERIVATIVES.
7. PROGENY: Unmodified descendant from the MATERIAL, such as virus from virus, cell from cell, or organism from organism, DNA/RNA duplicated by DNA/RNA supplied by the PROVIDER, purified or fractionated subsets of the ORIGINAL MATERIAL.
8. UNMODIFIED DERIVATIVES: Substances created by the RECIPIENT which constitute an unmodified functional subunit or product expressed by the ORIGINAL MATERIAL. Some examples include: proteins expressed by DNA/RNA supplied by the PROVIDER, or monoclonal antibodies secreted by a hybridoma cell line.
9. MODIFICATIONS: Substances created by the RECIPIENT which contain/incorporate the MATERIAL, and UNMODIFIED DERIVATIVES.
10. COMMERCIAL PURPOSES: The sale, lease, license, or other transfer of the MATERIAL or MODIFICATIONS to a for-profit organization. COMMERCIAL PURPOSES shall also include uses of the MATERIAL or MODIFICATIONS by any organization, including RECIPIENT, to perform contract research, to screen compound libraries, to produce or manufacture products for general sale, or to conduct research activities that result in any sale, lease, license, or transfer of the MATERIAL or MODIFICATIONS to a for-profit organization. However, industrially sponsored academic research shall not be considered a use of the MATERIAL or MODIFICATIONS for COMMERCIAL PURPOSES per se, unless any of the above conditions of this definition are met.
11. NONPROFIT ORGANIZATION(S): A university or other institution of higher education or an organization any nonprofit scientific or educational organization qualified under a nonprofit organization statute. As used herein, the term also includes government agencies.

Terms and Conditions of this Agreement

1. The PROVIDER retains ownership of the MATERIAL, including any MATERIAL contained or incorporated in MODIFICATIONS.

2. The RECIPIENT retains ownership of: (a) MODIFICATIONS (except that, the PROVIDER retains ownership rights to the MATERIAL included therein), and (b) those substances created through the use of the MATERIAL or MODIFICATIONS, but which are not PROGENY, UNMODIFIED DERIVATIVES or MODIFICATIONS (i.e., do not contain the ORIGINAL MATERIAL, PROGENY, UNMODIFIED DERIVATIVES). If either 2 (a) or 2 (b) results from the collaborative efforts of the PROVIDER and the RECIPIENT, joint ownership may be negotiated.

a) is to be used solely for teaching and academic research purposes;
b) will not be used in human subjects, in clinical trials, or for diagnostic purposes involving human subjects without the written consent of the PROVIDER;
c) is to be used only at the RECIPIENT organization and only in the RECIPIENT SCIENTIST's laboratory under the direction of the RECIPIENT SCIENTIST or others working under his/her direct supervision;
d) will not be transferred to anyone else outside the RECIPIENT organization without the prior written consent of the PROVIDER.

4. The RECIPIENT and the RECIPIENT SCIENTIST agree to refer to the PROVIDER any request for the MATERIAL from anyone other than those persons working under the RECIPIENT SCIENTIST's direct supervision. To the extent supplies are available, the PROVIDER or the PROVIDER SCIENTIST agrees to make the MATERIAL available, under a separate implementing letter to this Agreement or other agreement having terms consistent with the terms of this Agreement, to other scientists (at least those at NONPROFIT ORGANIZATION(S)) who wish to replicate the RECIPIENT SCIENTIST's research; provided that such other scientists reimburse the PROVIDER for any costs relating to the preparation and distribution of the MATERIAL.

a) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute substances created by the PROVIDER through the use of the ORIGINAL MATERIAL only if those substances are not PROGENY, UNMODIFIED DERIVATIVES, or MODIFICATIONS.
b) Under a separate implementing letter to this Agreement (or an agreement at least as protective of the PROVIDER's rights), the RECIPIENT and/or the RECIPIENT SCIENTIST may distribute substances created by the RECIPIENT through the use of the ORIGINAL MATERIAL only if those substances are not PROGENY, UNMODIFIED DERIVATIVES, or MODIFICATIONS.
c) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute MODIFICATIONS to NONPROFIT ORGANIZATION(S) for research and teaching purposes only.
d) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute MATERIAL for COMMERCIAL PURPOSES. It is recognized by the PROVIDER that such COMMERCIAL PURPOSES may NOT require a commercial license from the RECIPIENT and the RECIPIENT has no obligation to grant a commercial license to its ownership interest in the MATERIAL. Nothing in this paragraph, however, shall prevent the PROVIDER from granting commercial licenses under the PROVIDER's intellectual property rights claiming such MATERIAL, or methods of their manufacture or their use.
e) The RECIPIENT and/or the RECIPIENT SCIENTIST shall have the right, without restriction, to distribute MODIFICATIONS for COMMERCIAL PURPOSES. It is recognized by the RECIPIENT that such COMMERCIAL PURPOSES may NOT require a commercial license from the PROVIDER and the PROVIDER has no obligation to grant a commercial license to its ownership interest in the MATERIAL incorporated in the MODIFICATIONS. Nothing in this paragraph, however, shall prevent the RECIPIENT from granting commercial licenses under the RECIPIENT's intellectual property rights claiming such MODIFICATIONS, or methods of their manufacture or their use.

6. The RECIPIENT acknowledges that the MATERIAL is or may be the subject of a patent application. Except as provided in this Agreement, no express or implied licenses or other rights are provided to the RECIPIENT under any patents, patent applications, trade secrets or other proprietary rights of the PROVIDER, including any altered forms of the MATERIAL made by the PROVIDER. In particular, no express or implied licenses or other rights are provided to use the MATERIAL, MODIFICATIONS, or any related patents of the PROVIDER for COMMERCIAL PURPOSES.

7. If the RECIPIENT desires to use or license the MATERIAL for COMMERCIAL PURPOSES, the RECIPIENT agrees, in advance of such use, to negotiate in good faith with the PROVIDER to establish the terms of a commercial license. It is understood by the RECIPIENT that the PROVIDER shall have no obligation to grant such a license to the RECIPIENT, and may grant exclusive or non-exclusive commercial licenses to others, or sell or assign all or part of the rights in the MATERIAL to any third party(ies), subject to any pre-existing rights held by others and obligations to the Federal Government.

8. If the PROVIDER desires to use or license the MODIFICATIONS for COMMERCIAL PURPOSES, the PROVIDER agrees, in advance of such use, to negotiate in good faith with the RECIPIENT to establish the terms of a commercial license. It is understood by the PROVIDER that the RECIPIENT shall have no obligation to grant such a license to the PROVIDER, and may grant exclusive or non-exclusive commercial licenses to others, or sell or assign all or part of the rights in the MODIFICATIONS to any third party(ies), subject to any pre-existing rights held by others and obligations to theGovernment.

9. The PROVIDER is free to file patent application(s) claiming inventions made by the PROVIDER through the use of the MODIFICATIONS but agrees to notify the RECIPIENT upon filing a patent application claiming MATERIAL or method(s) of manufacture or use(s) of the MATERIAL.

10. The RECIPIENT is free to file patent application(s) claiming inventions made by the RECIPIENT through the use of the MATERIAL but agrees to notify the PROVIDER upon filing a patent application claiming MODIFICATIONS or method(s) of manufacture or use(s) of the MATERIAL.

11. Any MATERIAL delivered pursuant to this Agreement is understood to be experimental in nature and may have hazardous properties. The PROVIDER MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE MATERIAL WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS.

12. Except to the extent prohibited by law, the RECIPIENT assumes all liability for damages which may arise from its use, storage or disposal of the MATERIAL. The PROVIDER will not be liable to the RECIPIENT for any loss, claim or demand made by the RECIPIENT, or made against the RECIPIENT by any other party, due to or arising from the use of the MATERIAL by the RECIPIENT, except to the extent permitted by law when caused by the gross negligence or willful misconduct of the PROVIDER.

13. This agreement shall not be interpreted to prevent or delay publication of research findings resulting from the use of the MATERIAL or the MODIFICATIONS. The PROVIDER SCIENTIST agrees to provide appropriate acknowledgment of the source of the MODIFICATIONS in all publications. The RECIPIENT SCIENTIST agrees to provide appropriate acknowledgment of the source of the MATERIAL in all publications.

14. The PROVIDER agrees to use the MODIFICATIONS in compliance with all applicable statutes and regulations, including Public Health Service and National Institutes of Health regulations and guidelines such as, for example, those relating to research involving the use of animals or recombinant DNA. The RECIPIENT agrees to use the MATERIAL in compliance with all applicable statutes and regulations, including Public Health Service and National Institutes of Health regulations and guidelines such as, for example, those relating to research involving the use of animals or recombinant DNA.

i) if termination should occur under 15(a), the RECIPIENT shall be bound to the PROVIDER by the least restrictive terms applicable to the MATERIAL obtained from the then-available resources; and
ii) if termination should occur under 15(b) or (d) above, the RECIPIENT will discontinue its use of the MATERIAL and will, upon direction of the PROVIDER, return or destroy any remaining MATERIAL. The RECIPIENT, at its discretion, will also either destroy the MODIFICATIONS or remain bound by the terms of this agreement as they apply to MODIFICATIONS; and
iii) In the event the PROVIDER terminates this Agreement under 15( c) other than for breach of this Agreement or for cause such as an imminent health risk or patent infringement, the PROVIDER will defer the effective date of termination for a period of up to one year, upon request from the RECIPIENT, to permit completion of research in progress. Upon the effective date of termination, or if requested, the deferred effective date of termination, RECIPIENT will discontinue its use of the MATERIAL and will, upon direction of the PROVIDER, return or destroy any remaining MATERIAL. The RECIPIENT, at its discretion, will also either destroy the MODIFICATIONS or remain bound by the terms of this agreement as they apply to MODIFICATIONS.

16.Paragraphs 6, 11 and 12 shall survive termination.

17.The MATERIAL is provided at no cost, or with an optional transmittal fee solely to reimburse the PROVIDER for its preparation and distribution costs. If a fee is requested by the PROVIDER, the amount will be indicated in an implementing letter. Main Text Ends Here.

RECIPIENT: Kangma-Healthcode (Shanghai) Biotech Co. Ltd.
RECIPIENT SCIENTIST: Rongrong Zhan
RECIPIENT ADDRESS: Building 15, Lane 118 Furonghua Road, Shanghai 201321, CHINA
RECIPIENT TEL: 021-58086922
RECIPIENT EMAIL: customer@healthcodon.com

Protocol Specification

提示

阅读并同意隐私协议、MTA和使用条款后进行下一步!

InnoPAGE 10% Bis-Tris Precast Page Gel - 10 Well- OurProteinFactory

InnoPAGE 10% Bis-Tris Precast Page Gel - 10 Well

Product code

PROTN_IP10BTPPGN10M00001

299.45 ￥ 128.37

Size

InnoPAGE 4-20% Tris-Glycine POLYACRYLAMIDE GEL - 10 Well

InnoPAGE 4-20% Tris-Glycine POLYACRYLAMIDE GEL - 12 Well

InnoPage 4-20% Bis-Tris Gradient Page Gel - 10 Well

InnoPage 4-20% Bis-Tris Gradient Page Gel - 12 Well

Proexlle Quick InnoPage Electrophoresis Tank

Chamfer Cutter

InnoPage Empty Plate - 10 Well

InnoPage Empty Plate - 12 Well

InnoPage Void Plate

InnoPage Gel Casting Base

InnoPage Pre-Stained 3-Color Protein Marker - 100 Uses

InnoPage BritBlue Protein Loading Buffer 5x

InnoPage SDS BritBlue Protein Loading Buffer 5x

InnoPage SDS Reduced BritBlue Protein Loading Buffer 5x

InnoPAGE 10% Bis-Tris Precast Page Gel - 10 Well

InnoPAGE 10% Bis-Tris Precast Page Gel - 12 Well

InnoPAGE 10% Tris-Glycine Precast Page Gel - 10 Well

InnoPAGE 10% Tris-Glycine Precast Page Gel - 12 Well

Quantity

All of our products are guaranteed with with the 30-day return/refund policy. Please shop with 100% satisfaction.

Free shipping for order over $1000 USD.

Add To Cart

Order Now

Successfully added to shopping cart

Document

InnoPage™

世界上更大面积的梯度蛋白电泳预制胶

World's Largest Area Of Gradient Protein Electrophoresis Precasted Gel

Tris-Glycine

梯度电泳预制胶

InnoPage™ 4-20%

Tris-Glycine Polyacrylamide Gel

10 Well/12 Well.

Bis-Tris

梯度电泳预制胶

InnoPage™ 4-20%

Bis-Tris Gradient Page Gel

10 Well/12 Well.

更大上样量，更高检测灵敏度。

InnoPage™ 4-20%Gradient梯度预制胶，彩色指示，梯度裸眼可见。

1.5 mm 加厚胶层，V槽高达90 µL上样量，更高检测灵敏度。

InnoPage™ 预制胶中不含SDS，因此您使用的电泳Buffer中，如含有SDS，

可作为变性SDS-Page 胶使用；如不含SDS，可作为非变性Page 胶使用

Tris-glycine预制胶使用Tris-hepes的电泳buffer，效果更佳。 InnoPage Tris-Hepes Buffer: 20 mM Tris-base, 50 mM Hepes, 0.1% SDS, 2 mM EDTA

宽体设计

通用，一件就够了。

InnoPage™ 预制胶使用的是目前世界上更大面积的电泳胶面，制造成本更高。其独有的大面积，需要配套

Proexlle Quick™ 通用电泳槽使用。Proexlle Quick™ 通用电泳槽是向下兼容的，可适配目前市面上绝大部

分的玻璃和塑料电泳胶板，以及其他品牌的预制胶板。

梯度凝胶

出类拔萃，一看便知。

与分层凝胶相比，梯度凝胶分离范围更宽，条带更聚集清晰，不仅可以同时分离较大范围分子量的蛋白质，还

可以分辨分子量相差较小，在分层凝胶中不能分辨的蛋白质。梯度胶的制备难度要大于分层胶，但分离效果、

通用性、保质期都要优于混合（分层）胶，这些优点使得整体使用效果都要优于传统分层胶。InnoPage™

Tris-Gly 预制胶，推荐电泳buffer: Tris-Hepes-EDTA-(SDS)，电泳条件: 120-150v 45分钟。

得力配件

灌胶支撑底座，一气呵成。

InnoPage™ 系列预制胶板4℃环境储存有效期长达12个月。如果不满足，您甚至可以购买InnoPage™ 空胶

板（10孔或12孔上样梳），搭配InnoPage™ 灌胶支撑底座，轻松完成灌胶。

InnoPage™ 预制胶板通过pH中性缓冲液制备，4-20%丙烯酰胺，凝胶厚度1.5 mm，独有大面积需要配套 Proexlle Quick通用电泳槽使用，12孔/10孔梳齿，单孔上样量高达90 μL。
1）即开即用，不用再配制N种溶液、灌胶、等胶凝固，节省了宝贵的时间和精力；
2）不用接触几种具有积累性神经毒性的试剂（丙烯酰胺/甲叉丙烯酰胺：神经毒性和遗传毒性；TEMED：强神经毒；过硫酸铵：
可严重损伤呼吸道，眼睛，皮肤）；
3）大规模生产，胶与胶之间重复性好，质量稳定，不像手工灌胶那样结果差异大。
使用方法
1）剪开包装取出胶板，撕去胶板底端胶纸，将预制胶固定在电泳槽中，加入电泳缓冲液没过梳齿部位3~5 cm，双手按住胶板左右部
位将梳子平稳缓慢（一定要慢，否则会将胶齿拔断或拔歪）拔出，上样后进行电泳，电泳结束后取出胶板，用InnoPage Proteinn^®专
用电泳胶割刀沿两板间的缝隙轻轻撬动即可分离，将胶取出。废弃的塑料板可在清洗后按照购买时附赠的回收卡片地址寄回我司，
每100件合规的回收物可兑换价值100N币产品。
2）电泳：使用指定的电泳缓冲液，跑至电泳结束。
3）转膜：使用指定的电转缓冲液，操作与实验室原有操作完全相同。
储存条件：4℃环境下有效期12个月。
注意事项
1) 为了您的安全和健康，请穿实验服并戴一次性手套操作。
2) 本品含有的部分试剂如丙烯酰胺等有害成分，不可接触人体，请注意适当防护。
3) 电泳及电转缓冲液建议使用新配制的缓冲液，试剂纯度不够，反复使用或长期放置过的缓冲液会降低电泳效果。
4) 电泳前请务必撕去胶板底端的胶纸。
5) 拔掉梳子后，如果出现胶齿不直的情况，可用注射器针头将胶齿拨正。

以上页面中的产品图片仅作示意,实物产品效果(包括但不限于外观、颜色、尺寸)可能略有差异,请以实物为准。

实际使用中可能因产品个体差异、使用条件和环境因素不同而略有不同,请以实际使用的情况为准。

由于产品批次和生产供应因素实时变化,为尽可能提供准确的产品信息、规格参数、产品特性,PROTEINN®️可能实时

调整和修订以上页面中的文字表述、图片效果等内容,以求与实际产品性能规格、指数、零部件等信息相匹配。

如遇确有进行上述修改和调整必要的情形,恕不专门通知。

FOOT

More ways to contact,Building #12-15, Furonghua Road, Pudong District, Shanghai, China Zip: 200120， please call +1-800-955-3390or+86-400-770-5500Monday to Sunday 0:00-24:00